Vascular Web Logo

SVS  SVS Foundation

 PS176. Rescuing Effect of Autologous Mesenchymal Stem Cells in a Model of Early Type II Diabetes

Bo Wang, Runxia Tian, Zhao-Jun Liu, Alan Livingstone, Omaida C. Velazquez
Surgery, University of Miami, Miami, FL.

OBJECTIVES: Repeated, low-dose injections of streptozotocin (STZ) create a model of type II diabetes mellitus. We utilize this model to investigate the potential pro-repair effect of syngeneic (equivalent to autologous) bone marrow-derived mesenchymal stem cells (BMD-MSC) in diabetes.
METHODS: STZ (40mg/kg) was administered, daily, for five days, i.p., in C57BL6 mice (n=12). Weekly blood glucose levels (BG) were monitored by 2-hour glucose tolerance test (GTT) for 5 weeks after. Glucose intolerance (150<BG<200mg/dL) was used as the trigger for treatment. The mice were then divided in two groups (n=6/group). Control group received PBS and treatment group received MSC (1x10^6), by tail vein infusion. MSC were obtained by culturing BMD cells from donor mice (n=3) in MesenCult® medium. β-cell activity was measured by immunohistochemistry, and serum level of insulin was assessed by C-peptide test.
RESULTS: At baseline and post-STZ-induction, GTT between control and treatment group did not differ significantly. However, at week 3 the MSC treatment group's GTT normalized and the effect is sustained by week 5 (Figure 1). Control group continues to have significant glucose intolerance. Longer follow-up is ongoing.
CONCLUSIONS: Systemic injection of a single MSC treatment improves the glucose tolerance in a murine model of type II diabetes. The findings will require confirmation in genetic murine models, yet depict a highly promising novel concept for the treatment of diabetes.
AUTHOR DISCLOSURES: Z. Liu: Nothing to disclose; A. Livingstone: Nothing to disclose; R. Tian: Nothing to disclose; O. C. Velazquez: Nothing to disclose; B. Wang: Nothing to 176.jpg
Figure 1
Posted April 2013

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320

Follow Us


VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.